This inventor holds 2 USPTO granted patents. Top assignee: Abbott Laboratories Corporation. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: Innovations by Paul J Ropella
Introduction
Paul J Ropella is a notable inventor based in Racine, WI (US). He has made significant contributions to the field of agglutination immunoassay reactions. With a total of 2 patents, Ropella's work has advanced the technology used in various diagnostic applications.
Latest Patents
Ropella's latest patents include an "Agglutination reaction device having geometrically modified chambers." This device is designed to perform agglutination immunoassay reactions and features a unique structure that enhances the observation of aggregated particles. The device consists of a first hydrophilic layer, a second liquid-occlusive layer, and a third layer with a transparent opening. The geometry of the chamber is modified to create different flow rates, allowing for a non-random pattern of aggregated particles to form, which is easier to observe.
Another significant patent is the "Agglutination reaction device utilizing selectively impregnated porous material." This improved device incorporates a layer of liquid absorbent material that controls the overall rate of liquid flow through the chamber. The layer is selectively impregnated to create regions that are either liquid absorbent or liquid-occlusive, facilitating better communication of liquid within the chamber.
Career Highlights
Ropella is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work has contributed to the development of innovative diagnostic tools that enhance the accuracy and efficiency of immunoassays.
Collaborations
Some of Ropella's notable coworkers include Kevin J Forney and Robert G Parsons. Their collaborative efforts have played a crucial role in advancing the technologies developed at Abbott Laboratories Corporation.
Conclusion
Paul J Ropella's contributions to the field of agglutination immunoassay reactions through his innovative patents demonstrate his commitment to advancing medical technology. His work continues to impact the healthcare industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile